Medical device startup company CoapTech has received investor capital to support clinical testing, bringing its feeding tube placement technology closer to Food and Drug Administration approval. The company is based on the work of Steven Tropello, MD, MS, clinical instructor in emergency medicine at the University of Maryland School of Medicine.

The University of Maryland, Baltimore licensed exclusive rights to CoapTech in 2016 for the commercial development of a platform technology called Coaptive Ultrasound.

CoapTech was founded under the guidance of UM Ventures, an initiative of the University of Maryland Strategic Partnership: MPowering the State program designed to bring together the University of Maryland, Baltimore and the University of Maryland, College Park to commercialize discoveries and create economic impact by engaging partners in industry and social ventures.

Read more about CoapTech in this Baltimore Business Journal article.